Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17) - Image 1

£78.10

Springer Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17)

Name: Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17)
Brand: Springer
Price: 78.1 GBP
Availability: InStock

General Medical Issues

This is the usual price. Wait for it to drop, or tell us your number.

£78 today · usual range £0–£0 · best ever £12

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 631 days • 631 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 631 days • 3 price ranges

Days at Price

Current Price

Price Analysis

Most common range: £12-28 (398 days, 63.1%)

Price range: £12 - £90

Price levels: 3 price ranges over 631 days

Description

In the last decade, the literature on molecular mechanisms and activated pathways in the different lymphoma categories increased exponentially, which was followed by a more diffuse and successful use of targeted therapies. In this book, expert authors revisit the most relevant aspects of these therapies, with special emphasis on molecular mechanisms and clinical effects of resistance. The knowledge of the underlying mechanisms involved in tumor resistance to target therapies is of paramount importance because they will result in a better selection of patients with sensitive disease and the establishment of suitable combinations of drugs that target different molecules and could overcome the established resistance.

Product Specifications

Brand: Springer
Format: Hardcover
ASIN: 3319751832
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > General Medical Issues
Domain: Amazon UK
Release Date: 13 April 2018
Listed Since: 09 January 2018

Barcode

No barcode data available

Springer Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17)

This is the usual price. Wait for it to drop, or tell us your number.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Resistance to Ibritumomab in Lymphoma: 18 (Resistance to Targeted Anti-Cancer Therapeutics, 18)

Rare Lymphomas (Hematologic Malignancies)

Aggressive Lymphomas (Hematologic Malignancies)

Humana Lymphoma: Methods and Protocols - Methods in Molecular Biology

Springer - Molecular Mechanisms of Tumor Cell Resistance

Non-Hodgkin Lymphoma: Pathology, Imaging, and Current Therapy: 165 (Cancer Treatment and Research, 165)

Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)

Advances in Lymphoma Research: 85 (Cancer Treatment and Research, 85)

Drug Resistance in Leukemia and Lymphoma III: 457 (Advances in Experimental Medicine and Biology, 457)

Springer - Drug Resistance in Leukemia and Lymphoma III

Lymphoma: Methods and Protocols: 1956 (Methods in Molecular Biology, 1956)

Innovative Leukemia and Lymphoma Therapy: 35 (Basic and Clinical Oncology)

Cancer Therapy: Monoclonal Antibodies, Lymphokines New Developments in Surgical Oncology and Chemo- and Hormonal Therapy

Targeted Cancer Therapy: A Ha: A Handbook for Nurses

Malignant lymphomas, including Hodgkin’s disease: Diagnosis, management, and special problems: 66 (Cancer Treatment and Research, 66)

Radiotherapy for Hodgkin Lymphoma

Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)

New Trends in the Molecular and Biological Basis for Clinical Oncology

Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)

Lymphoma: Diagnosis and Treatment: 43 (Current Clinical Oncology, 43)

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Hodgkin’s Disease in Children: Controversies and Current Practice: 41 (Cancer Treatment and Research)

Blut und Blutkrankheiten: Fünfte Völlig Neu Bearbeitete und Erweiterte Auflage: 2 / 7 (Handbuch der inneren Medizin, 2 / 7)

Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)